In people with HIV taking antiretroviral therapy, excessive visceral abdominal fat drives cardiovascular disease risk, even ...

Badger Meter (BMI) closed the latest trading day at $182.17, indicating a -1.36% change from the previous session's end. The stock's performance was ahead of the S&P 500's daily loss of 3.46%.

Topline data were announced from a phase 3 trial evaluating setmelanotide for the treatment of acquired hypothalamic obesity.

Shaedra Byrd thought her extreme weight loss was because she was being active with her kids. But after realizing she had lost ...

Patients with solid tumor malignancies had better survival after ICI therapy if they were obese than if they had a normal BMI.

A group of children and adults with hypothalamic obesity receiving setmelanotide for 1 year had nearly a 20% greater BMI ...

Stifel analysts were bullish on the data, which showed a 16.5% drop in body-mass index among patients with damage to the ...